{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:22:35Z","timestamp":1791868955054,"version":"4.3.4"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T00:00:00Z","timestamp":1415145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00467-014-2958-5","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T16:29:36Z","timestamp":1415118576000},"page":"1407-1423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Drug-induced acid-base disorders"],"prefix":"10.1007","volume":"30","author":[{"given":"Daniel","family":"Kitterer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Dominik","family":"Alscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Latus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,5]]},"reference":[{"key":"2958_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2215\/CJN.03020906","volume":"2","author":"JA Kraut","year":"2007","unstructured":"Kraut JA, Madias NE (2007) Serum anion gap: its uses and limitations in clinical medicine. Clin J Am Soc Nephrol 2:162\u2013174","journal-title":"Clin J Am Soc Nephrol"},{"key":"2958_CR2","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.V891462","volume":"8","author":"BF Palmer","year":"1997","unstructured":"Palmer BF, Alpern RJ (1997) Metabolic alkalosis. J Am Soc Nephrol 8:1462\u20131469","journal-title":"J Am Soc Nephrol"},{"key":"2958_CR3","first-page":"83","volume":"18","author":"K Ishihara","year":"1998","unstructured":"Ishihara K, Szerlip HM (1998) Anion gap acidosis. Semin Nephrol 18:83\u201397","journal-title":"Semin Nephrol"},{"key":"2958_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(98)03087-6","volume":"352","author":"SL Gluck","year":"1998","unstructured":"Gluck SL (1998) Acid-base. Lancet 352:474\u2013479","journal-title":"Lancet"},{"issue":"Suppl 9","key":"2958_CR5","first-page":"S62","volume":"19","author":"HJ Adrogue","year":"2006","unstructured":"Adrogue HJ (2006) Metabolic acidosis: pathophysiology, diagnosis and management. J Nephrol Nurs 19(Suppl 9):S62\u2013S69","journal-title":"J Nephrol Nurs"},{"key":"2958_CR6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-3476(99)70096-X","volume":"135","author":"JM Lorenz","year":"1999","unstructured":"Lorenz JM, Kleinman LI, Markarian K, Oliver M, Fernandez J (1999) Serum anion gap in the differential diagnosis of metabolic acidosis in critically ill newborns. J Pediatr 135:751\u2013755","journal-title":"J Pediatr"},{"key":"2958_CR7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archinte.1990.00390140057012","volume":"150","author":"SD Winter","year":"1990","unstructured":"Winter SD, Pearson JR, Gabow PA, Schultz AL, Lepoff RB (1990) The fall of the serum anion gap. Arch Intern Med 150:311\u2013313","journal-title":"Arch Intern Med"},{"key":"2958_CR8","first-page":"221","volume":"5","author":"RN Singh","year":"1994","unstructured":"Singh RN, Singh NC, Hutchison J, Moses GC (1994) Lower anion gap increases sensitivity in predicting elevated lactate. Clin Intensive Care 5:221\u2013224","journal-title":"Clin Intensive Care"},{"key":"2958_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/IJNRD.S44689","volume":"6","author":"SA Sadjadi","year":"2013","unstructured":"Sadjadi SA, Manalo R, Jaipaul N, McMillan J (2013) Ion-selective electrode and anion gap range: what should the anion gap be? Int J Nephrol Renov Dis 6:101\u2013105","journal-title":"Int J Nephrol Renov Dis"},{"key":"2958_CR10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/adc.87.6.526","volume":"87","author":"M Hatherill","year":"2002","unstructured":"Hatherill M, Waggie Z, Purves L, Reynolds L, Argent A (2002) Correction of the anion gap for albumin in order to detect occult tissue anions in shock. Arch Dis Child 87:526\u2013529","journal-title":"Arch Dis Child"},{"key":"2958_CR11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.lab.2005.07.008","volume":"146","author":"M Feldman","year":"2005","unstructured":"Feldman M, Soni N, Dickson B (2005) Influence of hypoalbuminemia or hyperalbuminemia on the serum anion gap. J Lab Clin Med 146:317\u2013320","journal-title":"J Lab Clin Med"},{"key":"2958_CR12","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/00003246-199811000-00019","volume":"26","author":"J Figge","year":"1998","unstructured":"Figge J, Jabor A, Kazda A, Fencl V (1998) Anion gap and hypoalbuminemia. Crit Care Med 26:1807\u20131810","journal-title":"Crit Care Med"},{"key":"2958_CR13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0883-9441(94)90015-9","volume":"9","author":"JA Kruse","year":"1994","unstructured":"Kruse JA, Cadnapaphornchai P (1994) The serum osmole gap. J Crit Care 9:185\u2013197","journal-title":"J Crit Care"},{"key":"2958_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1553-2712.1999.tb00090.x","volume":"6","author":"KK McQuillen","year":"1999","unstructured":"McQuillen KK, Anderson AC (1999) Osmol gaps in the pediatric population. Acad Emerg Med 6:27\u201330","journal-title":"Acad Emerg Med"},{"key":"2958_CR15","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0196-0644(05)82292-9","volume":"19","author":"K Wrenn","year":"1990","unstructured":"Wrenn K (1990) The delta (delta) gap: an approach to mixed acid-base disorders. Ann Emerg Med 19:1310\u20131313","journal-title":"Ann Emerg Med"},{"key":"2958_CR16","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1681\/ASN.2006121408","volume":"18","author":"A Rastegar","year":"2007","unstructured":"Rastegar A (2007) Use of the DeltaAG\/DeltaHCO3- ratio in the diagnosis of mixed acid-base disorders. J Am Soc Nephrol 18:2429\u20132431","journal-title":"J Am Soc Nephrol"},{"key":"2958_CR17","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJM198212233072603","volume":"307","author":"HJ Adrogue","year":"1982","unstructured":"Adrogue HJ, Wilson H, Boyd AE 3rd, Suki WN, Eknoyan G (1982) Plasma acid\u2013base patterns in diabetic ketoacidosis. N Engl J Med 307:1603\u20131610","journal-title":"N Engl J Med"},{"key":"2958_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00000441-198610000-00003","volume":"292","author":"MB Goldstein","year":"1986","unstructured":"Goldstein MB, Bear R, Richardson RM, Marsden PA, Halperin ML (1986) The urine anion gap: a clinically useful index of ammonium excretion. Am J Med Sci 292:198\u2013202","journal-title":"Am J Med Sci"},{"key":"2958_CR19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-2143(99)90190-7","volume":"133","author":"B Kirschbaum","year":"1999","unstructured":"Kirschbaum B, Sica D, Anderson FP (1999) Urine electrolytes and the urine anion and osmolar gaps. J Lab Clin Med 133:597\u2013604","journal-title":"J Lab Clin Med"},{"key":"2958_CR20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1056\/NEJM198803103181002","volume":"318","author":"DC Batlle","year":"1988","unstructured":"Batlle DC, Hizon M, Cohen E, Gutterman C, Gupta R (1988) The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N Engl J Med 318:594\u2013599","journal-title":"N Engl J Med"},{"key":"2958_CR21","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.ki.5002776","volume":"73","author":"E Gonzalez","year":"2008","unstructured":"Gonzalez E, Gutierrez E, Galeano C, Chevia C, de Sequera P, Bernis C, Parra EG, Delgado R, Sanz M, Ortiz M, Goicoechea M, Quereda C, Olea T, Bouarich H, Hernandez Y, Segovia B, Praga M (2008) Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73:940\u2013946","journal-title":"Kidney Int"},{"key":"2958_CR22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1568005043340858","volume":"4","author":"F Rougier","year":"2004","unstructured":"Rougier F, Claude D, Maurin M, Maire P (2004) Aminoglycoside nephrotoxicity. Curr Drug Targets CNS Neurol Disord 4:153\u2013162","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"2958_CR23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clinthera.2010.01.019","volume":"32","author":"E Chiappini","year":"2010","unstructured":"Chiappini E, Conti C, Galli L, de Martino M (2010) Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review. Clin Ther 32:66\u201388","journal-title":"Clin Ther"},{"key":"2958_CR24","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/j.ijid.2009.10.002","volume":"14","author":"J Dotis","year":"2010","unstructured":"Dotis J, Iosifidis E, Ioannidou M, Roilides E (2010) Use of linezolid in pediatrics: a critical review. Int J Infect Dis 14:e638\u2013e648","journal-title":"Int J Infect Dis"},{"key":"2958_CR25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tube.2013.10.003","volume":"94","author":"AJ Garcia-Prats","year":"2014","unstructured":"Garcia-Prats AJ, Rose PC, Hesseling AC, Schaaf HS (2014) Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations. Tuberculosis (Edinb) 94:93\u2013104","journal-title":"Tuberculosis (Edinb)"},{"key":"2958_CR26","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1097\/01.inf.0000087022.58089.d8","volume":"22","author":"L Saiman","year":"2003","unstructured":"Saiman L, Goldfarb J, Kaplan SA, Wible K, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB (2003) Safety and tolerability of linezolid in children. Pediatr Infect Dis J 22:S193\u2013S200","journal-title":"Pediatr Infect Dis J"},{"key":"2958_CR27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM200301023480123","volume":"348","author":"AA Apodaca","year":"2003","unstructured":"Apodaca AA, Rakita RM (2003) Linezolid-induced lactic acidosis. N Engl J Med 348:86\u201387","journal-title":"N Engl J Med"},{"key":"2958_CR28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/INF.0b013e3182186035","volume":"30","author":"E Su","year":"2011","unstructured":"Su E, Crowley K, Carcillo JA, Michaels MG (2011) Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children. Pediatr Infect Dis J 30:804\u2013806","journal-title":"Pediatr Infect Dis J"},{"key":"2958_CR29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s15010-008-7329-3","volume":"36","author":"P Scotton","year":"2008","unstructured":"Scotton P, Fuser R, Torresan S, Carniato A, Giobbia M, Rossi C, Inojosa WO, Vaglia A (2008) Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis. Infection 36:387\u2013388","journal-title":"Infection"},{"key":"2958_CR30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","volume":"42","author":"AS Vriese De","year":"2006","unstructured":"De Vriese AS, Coster RV, Smet J, Seneca S, Lovering A, Van Haute LL, Vanopdenbosch LJ, Martin JJ, Groote CC, Vandecasteele S, Boelaert JR (2006) Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 42:1111\u20131117","journal-title":"Clin Infect Dis"},{"key":"2958_CR31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/AAC.01190-06","volume":"51","author":"G Garrabou","year":"2007","unstructured":"Garrabou G, Soriano A, Lopez S, Guallar JP, Giralt M, Villarroya F, Martinez JA, Casademont J, Cardellach F, Mensa J, Miro O (2007) Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother 51:962\u2013967","journal-title":"Antimicrob Agents Chemother"},{"key":"2958_CR32","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJM200511243532123","volume":"353","author":"A Soriano","year":"2005","unstructured":"Soriano A, Miro O, Mensa J (2005) Mitochondrial toxicity associated with linezolid. N Engl J Med 353:2305\u20132306","journal-title":"N Engl J Med"},{"key":"2958_CR33","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1086\/430441","volume":"40","author":"L Palenzuela","year":"2005","unstructured":"Palenzuela L, Hahn NM, Nelson RP Jr, Arno JN, Schobert C, Bethel R, Ostrowski LA, Sharma MR, Datta PP, Agrawal RK, Schwartz JE, Hirano M (2005) Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis? Clin Infect Dis 40:e113\u2013e116","journal-title":"Clin Infect Dis"},{"key":"2958_CR34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1592\/phco.27.5.771","volume":"27","author":"J Carson","year":"2007","unstructured":"Carson J, Cerda J, Chae JH, Hirano M, Maggiore P (2007) Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism. Pharmacotherapy 27:771\u2013774","journal-title":"Pharmacotherapy"},{"key":"2958_CR35","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/j.ejim.2008.12.002","volume":"20","author":"D Boutoille","year":"2009","unstructured":"Boutoille D, Grossi O, Depatureaux A, Tattevin P (2009) Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosis. Eur J Int Med 20:e134\u2013e135","journal-title":"Eur J Int Med"},{"key":"2958_CR36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00023210-200317040-00003","volume":"17","author":"K McKeage","year":"2003","unstructured":"McKeage K, Perry CM (2003) Propofol: a review of its use in intensive care sedation of adults. CNS Drugs 17:235\u2013272","journal-title":"CNS Drugs"},{"key":"2958_CR37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9592.2010.03454.x","volume":"21","author":"AE Rigby-Jones","year":"2011","unstructured":"Rigby-Jones AE, Sneyd JR (2011) Propofol and children\u2013what we know and what we do not know. Paediatr Anaesth 21:247\u2013254","journal-title":"Paediatr Anaesth"},{"key":"2958_CR38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0885066610384195","volume":"26","author":"DA Diedrich","year":"2011","unstructured":"Diedrich DA, Brown DR (2011) Analytic reviews: propofol infusion syndrome in the ICU. J Intensive Care Med 26:59\u201372","journal-title":"J Intensive Care Med"},{"key":"2958_CR39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/ANA.0b013e3181963471","volume":"21","author":"V Bonhomme","year":"2009","unstructured":"Bonhomme V, Demoitie J, Schaub I, Hans P (2009) Acid\u2013base status and hemodynamic stability during propofol and sevoflurane-based anesthesia in patients undergoing uncomplicated intracranial surgery. J Neurosurg Anesthesiol 21:112\u2013119","journal-title":"J Neurosurg Anesthesiol"},{"key":"2958_CR40","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc8145","volume":"13","author":"RJ Roberts","year":"2009","unstructured":"Roberts RJ, Barletta JF, Fong JJ, Schumaker G, Kuper PJ, Papadopoulos S, Yogaratnam D, Kendall E, Xamplas R, Gerlach AT, Szumita PM, Anger KE, Arpino PA, Voils SA, Grgurich P, Ruthazer R, Devlin JW (2009) Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care 13:R169","journal-title":"Crit Care"},{"key":"2958_CR41","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/PCC.0000000000000021","volume":"15","author":"H Koriyama","year":"2014","unstructured":"Koriyama H, Duff JP, Guerra GG, Chan AW (2014) Is propofol a friend or a foe of the pediatric intensivist? Description of propofol use in a PICU*. Pediatr Crit Care Med 15:e66\u2013e71","journal-title":"Pediatr Crit Care Med"},{"key":"2958_CR42","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/PCC.0b013e3182388a95","volume":"13","author":"MA Kruessell","year":"2012","unstructured":"Kruessell MA, Udink ten Cate FE, Kraus AJ, Roth B, Trieschmann U (2012) Use of propofol in pediatric intensive care units: a national survey in Germany. Pediatr Crit Care Med 13:e150\u2013e154","journal-title":"Pediatr Crit Care Med"},{"key":"2958_CR43","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0140-6736(99)90018-1","volume":"353","author":"DJ Hatch","year":"1999","unstructured":"Hatch DJ (1999) Propofol-infusion syndrome in children. Lancet 353:1117\u20131118","journal-title":"Lancet"},{"key":"2958_CR44","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2044.2007.05055.x","volume":"62","author":"PC Kam","year":"2007","unstructured":"Kam PC, Cardone D (2007) Propofol infusion syndrome. Anaesthesia 62:690\u2013701","journal-title":"Anaesthesia"},{"key":"2958_CR45","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00134-003-2130-3","volume":"30","author":"M Koch","year":"2004","unstructured":"Koch M, De Backer D, Vincent JL (2004) Lactic acidosis: an early marker of propofol infusion syndrome? Intensive Care Med 30:522","journal-title":"Intensive Care Med"},{"key":"2958_CR46","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(00)04064-2","volume":"357","author":"A Wolf","year":"2001","unstructured":"Wolf A, Weir P, Segar P, Stone J, Shield J (2001) Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 357:606\u2013607","journal-title":"Lancet"},{"key":"2958_CR47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1460-9592.2004.01299.x","volume":"14","author":"DE Withington","year":"2004","unstructured":"Withington DE, Decell MK, Al Ayed T (2004) A case of propofol toxicity: further evidence for a causal mechanism. Paediatr Anaesth 14:505\u2013508","journal-title":"Paediatr Anaesth"},{"key":"2958_CR48","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2215\/CJN.03220807","volume":"3","author":"JA Kraut","year":"2008","unstructured":"Kraut JA, Kurtz I (2008) Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol 3:208\u2013225","journal-title":"Clin J Am Soc Nephrol"},{"key":"2958_CR49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1525-139X.2007.00280.x","volume":"20","author":"T Zar","year":"2007","unstructured":"Zar T, Graeber C, Perazella MA (2007) Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dial 20:217\u2013219","journal-title":"Semin Dial"},{"key":"2958_CR50","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM200204183461618","volume":"346","author":"J Tayar","year":"2002","unstructured":"Tayar J, Jabbour G, Saggi SJ (2002) Severe hyperosmolar metabolic acidosis due to a large dose of intravenous lorazepam. N Engl J Med 346:1253\u20131254","journal-title":"N Engl J Med"},{"key":"2958_CR51","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1378\/chest.128.3.1674","volume":"128","author":"KC Wilson","year":"2005","unstructured":"Wilson KC, Reardon C, Theodore AC, Farber HW (2005) Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest 128:1674\u20131681","journal-title":"Chest"},{"key":"2958_CR52","doi-asserted-by":"crossref","unstructured":"Yahwak JA, Riker RR, Fraser GL, Subak-Sharpe S (2003) An observational pilot study of osmolar gap monitoring to detect propylene glycol toxicity in adult icu patients receiving high-dose lorazepam. CHEST Journal 124:178S-a","DOI":"10.1378\/chest.124.4_MeetingAbstracts.178S-a"},{"key":"2958_CR53","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/PCC.0b013e31819a383c","volume":"10","author":"N Shehab","year":"2009","unstructured":"Shehab N, Lewis CL, Streetman DD, Donn SM (2009) Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit Care Med 10:256\u2013259","journal-title":"Pediatr Crit Care Med"},{"key":"2958_CR54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijpharm.2012.05.014","volume":"435","author":"A Kulo","year":"2012","unstructured":"Kulo A, de Hoon JN, Allegaert K (2012) The propylene glycol research project to illustrate the feasibility and difficulties to study toxicokinetics in neonates. Int J Pharm 435:112\u2013114","journal-title":"Int J Pharm"},{"key":"2958_CR55","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/adc.2010.190330","volume":"95","author":"K Allegaert","year":"2010","unstructured":"Allegaert K, Vanhaesebrouck S, Kulo A, Cosaert K, Verbesselt R, Debeer A, de Hoon J (2010) Prospective assessment of short-term propylene glycol tolerance in neonates. Arch Dis Child 95:1054\u20131058","journal-title":"Arch Dis Child"},{"key":"2958_CR56","first-page":"857","volume":"347","author":"ME Mullins","year":"2002","unstructured":"Mullins ME, Barnes BJ (2002) Hyperosmolar metabolic acidosis and intravenous Lorazepam. N Engl J Med 347:857\u2013858, author reply 857\u2013858","journal-title":"N Engl J Med"},{"key":"2958_CR57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.25.1.89","volume":"25","author":"KL Jones","year":"2002","unstructured":"Jones KL, Arslanian S, Peterokova VA, Park JS, Tomlinson MJ (2002) Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 25:89\u201394","journal-title":"Diabetes Care"},{"key":"2958_CR58","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1592\/phco.24.9.871.36099","volume":"24","author":"AS Gaylor","year":"2004","unstructured":"Gaylor AS, Condren ME (2004) Type 2 diabetes mellitus in the pediatric population. Pharmacotherapy 24:871\u2013878","journal-title":"Pharmacotherapy"},{"key":"2958_CR59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","volume":"137","author":"D Kirpichnikov","year":"2002","unstructured":"Kirpichnikov D, McFarlane SI, Sowers JR (2002) Metformin: an update. Ann Intern Med 137:25\u201333","journal-title":"Ann Intern Med"},{"key":"2958_CR60","doi-asserted-by":"crossref","unstructured":"Salpeter SR, Greyber E, Pasternak GA, Salpeter EE (2010) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev CD002967","DOI":"10.1002\/14651858.CD002967.pub3"},{"key":"2958_CR61","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/diacare.21.10.1659","volume":"21","author":"JB Brown","year":"1998","unstructured":"Brown JB, Pedula K, Barzilay J, Herson MK, Latare P (1998) Lactic acidosis rates in type 2 diabetes. Diabetes Care 21:1659\u20131663","journal-title":"Diabetes Care"},{"key":"2958_CR62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199801223380415","volume":"338","author":"RI Misbin","year":"1998","unstructured":"Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA (1998) Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 338:265\u2013266","journal-title":"N Engl J Med"},{"key":"2958_CR63","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1345\/1542-6270(2000)034<1385:MCSOPM>2.0.CO;2","volume":"34","author":"HA Spiller","year":"2000","unstructured":"Spiller HA, Weber JA, Winter ML, Klein-Schwartz W, Hofman M, Gorman SE, Stork CM, Krenzelok EP (2000) Multicenter case series of pediatric metformin ingestion. Ann Pharmacother 34:1385\u20131388","journal-title":"Ann Pharmacother"},{"issue":"Pt 3","key":"2958_CR64","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348(Pt 3):607\u2013614","journal-title":"Biochem J"},{"key":"2958_CR65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","volume":"275","author":"MY El-Mir","year":"2000","unstructured":"El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X (2000) Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275:223\u2013228","journal-title":"J Biol Chem"},{"key":"2958_CR66","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1432-1033.1972.tb01846.x","volume":"27","author":"G Schafer","year":"1972","unstructured":"Schafer G, Bojanowski D (1972) Interaction of biguanides with mitochondrial and synthetic membranes. Eur J Biochem 27:364\u2013375","journal-title":"Eur J Biochem"},{"key":"2958_CR67","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/CCM.0b013e3181a02490","volume":"37","author":"A Seidowsky","year":"2009","unstructured":"Seidowsky A, Nseir S, Houdret N, Fourrier F (2009) Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 37:2191\u20132196","journal-title":"Crit Care Med"},{"key":"2958_CR68","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2215\/CJN.01411005","volume":"1","author":"AZ Fenves","year":"2006","unstructured":"Fenves AZ, Kirkpatrick HM 3rd, Patel VV, Sweetman L, Emmett M (2006) Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol 1:441\u2013447","journal-title":"Clin J Am Soc Nephrol"},{"key":"2958_CR69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5694\/j.1326-5377.2006.tb00537.x","volume":"185","author":"JV Peter","year":"2006","unstructured":"Peter JV, Rogers N, Murty S, Gerace R, Mackay R, Peake SL (2006) An unusual cause of severe metabolic acidosis. Med J Aust 185:223\u2013225","journal-title":"Med J Aust"},{"key":"2958_CR70","first-page":"351","volume":"66","author":"EJ Rolleman","year":"2008","unstructured":"Rolleman EJ, Hoorn EJ, Didden P, Zietse R (2008) Guilty as charged: unmeasured urinary anions in a case of pyroglutamic acidosis. Neth J Med 66:351\u2013353","journal-title":"Neth J Med"},{"key":"2958_CR71","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ki.1997.85","volume":"51","author":"TD DuBose Jr","year":"1997","unstructured":"DuBose TD Jr (1997) Hyperkalemic hyperchloremic metabolic acidosis: pathophysiologic insights. Kidney Int 51:591\u2013602","journal-title":"Kidney Int"},{"key":"2958_CR72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1681\/ASN.2008020166","volume":"20","author":"FE Karet","year":"2009","unstructured":"Karet FE (2009) Mechanisms in hyperkalemic renal tubular acidosis. J Am Soc Nephrol 20:251\u2013254","journal-title":"J Am Soc Nephrol"},{"key":"2958_CR73","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.HYP.34.1.96","volume":"34","author":"JL Wang","year":"1999","unstructured":"Wang JL, Cheng HF, Harris RC (1999) Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension 34:96\u2013101","journal-title":"Hypertension"},{"key":"2958_CR74","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2215\/CJN.00890805","volume":"1","author":"RC Harris","year":"2006","unstructured":"Harris RC, Breyer MD (2006) Update on cyclooxygenase-2 inhibitors. Clin J Am Soc Nephrol 1:236\u2013245","journal-title":"Clin J Am Soc Nephrol"},{"key":"2958_CR75","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1210\/jcem-56-1-108","volume":"56","author":"R O'Kelly","year":"1983","unstructured":"O'Kelly R, Magee F, McKenna TJ (1983) Routine heparin therapy inhibits adrenal aldosterone production. J Clin Endocrinol Metab 56:108\u2013112","journal-title":"J Clin Endocrinol Metab"},{"key":"2958_CR76","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000167106","volume":"6","author":"RA Sherman","year":"1986","unstructured":"Sherman RA, Ruddy MC (1986) Suppression of aldosterone production by low-dose heparin. Am J Nephrol 6:165\u2013168","journal-title":"Am J Nephrol"},{"key":"2958_CR77","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(05)63723-3","volume":"349","author":"CR Canova","year":"1997","unstructured":"Canova CR, Fischler MP, Reinhart WH (1997) Effect of low-molecular-weight heparin on serum potassium. Lancet 349:1447\u20131448","journal-title":"Lancet"},{"key":"2958_CR78","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(05)62260-X","volume":"350","author":"MI Wiggam","year":"1997","unstructured":"Wiggam MI, Beringer TR (1997) Effect of low-molecular-weight heparin on serum concentrations of potassium. Lancet 350:292\u2013293","journal-title":"Lancet"},{"key":"2958_CR79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1067\/mlc.2000.110371","volume":"136","author":"A Henger","year":"2000","unstructured":"Henger A, Tutt P, Riesen WF, Hulter HN, Krapf R (2000) Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients. J Lab Clin Med 136:379\u2013389","journal-title":"J Lab Clin Med"},{"key":"2958_CR80","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/01.HYP.25.3.443","volume":"25","author":"P Gupta","year":"1995","unstructured":"Gupta P, Franco-Saenz R, Mulrow PJ (1995) Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin-, and potassium-stimulated aldosterone secretion. Hypertension 25:443\u2013448","journal-title":"Hypertension"},{"key":"2958_CR81","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000167591","volume":"8","author":"T Sakemi","year":"1988","unstructured":"Sakemi T, Ohchi N, Sanai T, Rikitake O, Maeda T (1988) Captopril-induced metabolic acidosis with hyperkalemia. Am J Nephrol 8:245\u2013248","journal-title":"Am J Nephrol"},{"key":"2958_CR82","first-page":"S196","volume":"25","author":"D Durand","year":"1988","unstructured":"Durand D, Ader JL, Rey JP, Tran-Van T, Lloveras JJ, Bernadet P, Suc JM (1988) Inducing hyperkalemia by converting enzyme inhibitors and heparin. Kidney Int Suppl 25:S196\u2013S197","journal-title":"Kidney Int Suppl"},{"key":"2958_CR83","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semnephrol.2011.09.009","volume":"31","author":"BF Palmer","year":"2011","unstructured":"Palmer BF (2011) Metabolic complications associated with use of diuretics. Semin Nephrol 31:542\u2013552","journal-title":"Semin Nephrol"},{"key":"2958_CR84","first-page":"282","volume":"8","author":"TD DuBose Jr","year":"1988","unstructured":"DuBose TD Jr, Good DW (1988) Effects of diuretics on renal acid\u2013base transport. Semin Nephrol 8:282\u2013294","journal-title":"Semin Nephrol"},{"issue":"Suppl 5","key":"2958_CR85","first-page":"S112","volume":"15","author":"CA Wagner","year":"2002","unstructured":"Wagner CA, Geibel JP (2002) Acid\u2013base transport in the collecting duct. J Nephrol 15(Suppl 5):S112\u2013S127","journal-title":"J Nephrol"},{"key":"2958_CR86","first-page":"F383","volume":"244","author":"S Sastrasinh","year":"1983","unstructured":"Sastrasinh S, Tannen RL (1983) Effect of potassium on renal NH3 production. Am J Physiol 244:F383\u2013F391","journal-title":"Am J Physiol"},{"key":"2958_CR87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000089682","volume":"102","author":"S Muto","year":"2006","unstructured":"Muto S, Tsuruoka S, Miyata Y, Fujimura A, Kusano E (2006) Effect of trimethoprim-sulfamethoxazole on Na and K\u2009+\u2009transport properties in the rabbit cortical collecting duct perfused in vitro. Nephron Physiol 102:51\u201360","journal-title":"Nephron Physiol"},{"key":"2958_CR88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/0003-4819-122-2-199501150-00004","volume":"122","author":"TR Kleyman","year":"1995","unstructured":"Kleyman TR, Roberts C, Ling BN (1995) A mechanism for pentamidine-induced hyperkalemia: inhibition of distal nephron sodium transport. Ann Intern Med 122:103\u2013106","journal-title":"Ann Intern Med"},{"key":"2958_CR89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0022-3476(05)81194-1","volume":"121","author":"A Caldas","year":"1992","unstructured":"Caldas A, Broyer M, Dechaux M, Kleinknecht C (1992) Primary distal tubular acidosis in childhood: clinical study and long-term follow-up of 28 patients. J Pediatr 121:233\u2013241","journal-title":"J Pediatr"},{"key":"2958_CR90","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1097\/01.ASN.0000023430.92674.E5","volume":"13","author":"J Rodriguez Soriano","year":"2002","unstructured":"Rodriguez Soriano J (2002) Renal tubular acidosis: the clinical entity. J Am Soc Nephrol 13:2160\u20132170","journal-title":"J Am Soc Nephrol"},{"key":"2958_CR91","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1681\/ASN.V62154","volume":"6","author":"BP Sawaya","year":"1995","unstructured":"Sawaya BP, Briggs JP, Schnermann J (1995) Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. J Am Soc Nephrol 6:154\u2013164","journal-title":"J Am Soc Nephrol"},{"key":"2958_CR92","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9343(69)90067-9","volume":"46","author":"JB Douglas","year":"1969","unstructured":"Douglas JB, Healy JK (1969) Nephrotoxic effects of amphotericin B, including renal tubular acidosis. Am J Med 46:154\u2013162","journal-title":"Am J Med"},{"key":"2958_CR93","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(72)90117-9","volume":"53","author":"JL Burges","year":"1972","unstructured":"Burges JL, Birchall R (1972) Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function. Am J Med 53:77\u201384","journal-title":"Am J Med"},{"key":"2958_CR94","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI106270","volume":"49","author":"PR Steinmetz","year":"1970","unstructured":"Steinmetz PR, Lawson LR (1970) Defect in urinary acidification induced in vitro by amphotericin B. J Clin Invest 49:596\u2013601","journal-title":"J Clin Invest"},{"key":"2958_CR95","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9343(87)90691-7","volume":"83","author":"AM Stamm","year":"1987","unstructured":"Stamm AM, Diasio RB, Dismukes WE, Shadomy S, Cloud GA, Bowles CA, Karam GH, Espinel-Ingroff A (1987) Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med 83:236\u2013242","journal-title":"Am J Med"},{"key":"2958_CR96","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/archinte.1979.03630380064021","volume":"139","author":"GL Barbour","year":"1979","unstructured":"Barbour GL, Straub KD, O'Neal BL, Leatherman JW (1979) Vasopressin-resistant nephrogenic diabetes insipidus. A result of amphotericin B therapy. Arch Intern Med 139:86\u201388","journal-title":"Arch Intern Med"},{"key":"2958_CR97","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ncpneph0424","volume":"3","author":"EJ Hoorn","year":"2007","unstructured":"Hoorn EJ, Zietse R (2007) Combined renal tubular acidosis and diabetes insipidus in hematological disease. Nat Clin Pract Nephrol 3:171\u2013175","journal-title":"Nat Clin Pract Nephrol"},{"key":"2958_CR98","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/11316080-000000000-00000","volume":"11","author":"BC Marshall","year":"2009","unstructured":"Marshall BC, Koch WC (2009) Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events. Paediatr Drugs 11:309\u2013321","journal-title":"Paediatr Drugs"},{"key":"2958_CR99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/INF.0b013e3181598315","volume":"27","author":"T Hatchette","year":"2008","unstructured":"Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL (2008) Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature. Pediatr Infect Dis J 27:75\u201377","journal-title":"Pediatr Infect Dis J"},{"key":"2958_CR100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000167987","volume":"9","author":"G Deray","year":"1989","unstructured":"Deray G, Martinez F, Katlama C, Levaltier B, Beaufils H, Danis M, Rozenheim M, Baumelou A, Dohin E, Gentilini M, Jacobs C (1989) Foscarnet nephrotoxicity: mechanism, incidence and prevention. Am J Nephrol 9:316\u2013321","journal-title":"Am J Nephrol"},{"key":"2958_CR101","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","volume":"45","author":"H Izzedine","year":"2005","unstructured":"Izzedine H, Launay-Vacher V, Deray G (2005) Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45:804\u2013817","journal-title":"Am J Kidney Dis"},{"key":"2958_CR102","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0272-6386(96)90369-8","volume":"27","author":"JF Navarro","year":"1996","unstructured":"Navarro JF, Quereda C, Quereda C, Gallego N, Antela A, Mora C, Ortuno J (1996) Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy. Am J Kidney Dis 27:431\u2013434","journal-title":"Am J Kidney Dis"},{"key":"2958_CR103","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF00868266","volume":"8","author":"T Igarashi","year":"1994","unstructured":"Igarashi T, Ishii T, Watanabe K, Hayakawa H, Horio K, Sone Y, Ohga K (1994) Persistent isolated proximal renal tubular acidosis\u2013a systemic disease with a distinct clinical entity. Pediatr Nephrol 8:70\u201371","journal-title":"Pediatr Nephrol"},{"key":"2958_CR104","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0022-3476(72)80124-0","volume":"80","author":"MA Nash","year":"1972","unstructured":"Nash MA, Torrado AD, Greifer I, Spitzer A, Edelmann CM Jr (1972) Renal tubular acidosis in infants and children. Clinical course, response to treatment, and prognosis. J Pediatr 80:738\u2013748","journal-title":"J Pediatr"},{"key":"2958_CR105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00467-004-1771-y","volume":"20","author":"SY Hsu","year":"2005","unstructured":"Hsu SY, Tsai IJ, Tsau YK (2005) Comparison of growth in primary Fanconi syndrome and proximal renal tubular acidosis. Pediatr Nephrol 20:460\u2013464","journal-title":"Pediatr Nephrol"},{"key":"2958_CR106","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/pbc.20858","volume":"48","author":"W Stohr","year":"2007","unstructured":"Stohr W, Paulides M, Bielack S, Jurgens H, Treuner J, Rossi R, Langer T, Beck JD (2007) Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer 48:447\u2013452","journal-title":"Pediatr Blood Cancer"},{"key":"2958_CR107","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1200\/JCO.1991.9.8.1495","volume":"9","author":"CB Pratt","year":"1991","unstructured":"Pratt CB, Meyer WH, Jenkins JJ, Avery L, McKay CP, Wyatt RJ, Hancock ML (1991) Ifosfamide, Fanconi's syndrome, and rickets. J Clin Oncol 9:1495\u20131499","journal-title":"J Clin Oncol"},{"key":"2958_CR108","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<177::AID-MPO3>3.0.CO;2-H","volume":"32","author":"R Rossi","year":"1999","unstructured":"Rossi R, Pleyer J, Schafers P, Kuhn N, Kleta R, Deufel T, Jurgens H (1999) Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients. Med Pediatr Oncol 32:177\u2013182","journal-title":"Med Pediatr Oncol"},{"key":"2958_CR109","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(96)03480-0","volume":"348","author":"R Skinner","year":"1996","unstructured":"Skinner R, Pearson AD, English MW, Price L, Wyllie RA, Coulthard MG, Craft AW (1996) Risk factors for ifosfamide nephrotoxicity in children. Lancet 348:578\u2013580","journal-title":"Lancet"},{"key":"2958_CR110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1203\/00006450-196703000-00001","volume":"1","author":"J Rodriguez Soriano","year":"1967","unstructured":"Rodriguez Soriano J, Boichis H, Stark H, Edelmann CM Jr (1967) Proximal renal tubular acidosis. A defect in bicarbonate reabsorption with normal urinary acidification. Pediatr Res 1:81\u201398","journal-title":"Pediatr Res"},{"key":"2958_CR111","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/ajkd.2003.50037","volume":"41","author":"H Izzedine","year":"2003","unstructured":"Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G (2003) Drug-induced Fanconi's syndrome. Am J Kidney Dis 41:292\u2013309","journal-title":"Am J Kidney Dis"},{"key":"2958_CR112","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/qjmed\/hct258","volume":"107","author":"AM Hall","year":"2014","unstructured":"Hall AM, Bass P, Unwin RJ (2014) Drug-induced renal Fanconi syndrome. QJM 107:261\u2013269","journal-title":"QJM"},{"key":"2958_CR113","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1093\/ndt\/gfs493","volume":"27","author":"SK Haque","year":"2012","unstructured":"Haque SK, Ariceta G, Batlle D (2012) Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant 27:4273\u20134287","journal-title":"Nephrol Dial Transplant"},{"key":"2958_CR114","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/mpo.2950210906","volume":"21","author":"MC Stevens","year":"1993","unstructured":"Stevens MC, Brandis M (1993) Incidence and etiology of ifosfamide nephrotoxicity: report of a meeting held in Rhodes, Greece, October 3, 1991, sponsored by Asta Medica, Frankfurt, Germany. Med Pediatr Oncol 21:640\u2013644","journal-title":"Med Pediatr Oncol"},{"key":"2958_CR115","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1054\/bjoc.2000.1214","volume":"82","author":"R Skinner","year":"2000","unstructured":"Skinner R, Cotterill SJ, Stevens MC (2000) Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group. Br J Cancer 82:1636\u20131645","journal-title":"Br J Cancer"},{"key":"2958_CR116","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/(SICI)1096-911X(199701)28:1<62::AID-MPO12>3.0.CO;2-C","volume":"28","author":"MS Ashraf","year":"1997","unstructured":"Ashraf MS, Skinner R, English MW, Craft AW, Pearson AD (1997) Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child. Med Pediatr Oncol 28:62\u201364","journal-title":"Med Pediatr Oncol"},{"key":"2958_CR117","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00204-007-0275-5","volume":"82","author":"Z Yaseen","year":"2008","unstructured":"Yaseen Z, Michoudet C, Baverel G, Dubourg L (2008) Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule. Arch Toxicol 82:607\u2013614","journal-title":"Arch Toxicol"},{"key":"2958_CR118","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/(SICI)1096-911X(199807)31:1<40::AID-MPO11>3.0.CO;2-6","volume":"31","author":"F Cachat","year":"1998","unstructured":"Cachat F, Nenadov-Beck M, Guignard JP (1998) Occurrence of an acute Fanconi syndrome following cisplatin chemotherapy. Med Pediatr Oncol 31:40\u201341","journal-title":"Med Pediatr Oncol"},{"key":"2958_CR119","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11739-009-0331-7","volume":"5","author":"A Negro","year":"2010","unstructured":"Negro A, Grasselli C, Galli P (2010) Oxaliplatin-induced proximal renal tubular acidosis. Intern Emerg Med 5:267\u2013268","journal-title":"Intern Emerg Med"},{"key":"2958_CR120","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/annonc\/mdm080","volume":"18","author":"M Linch","year":"2007","unstructured":"Linch M, Cunningham D, Mingo O, Stiles A, Farquhar-Smith WP (2007) Renal tubular acidosis due to oxaliplatin. Ann Oncol 18:805\u2013806","journal-title":"Ann Oncol"},{"key":"2958_CR121","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/sj.ki.5000433","volume":"69","author":"D Portilla","year":"2006","unstructured":"Portilla D, Li S, Nagothu KK, Megyesi J, Kaissling B, Schnackenberg L, Safirstein RL, Beger RD (2006) Metabolomic study of cisplatin-induced nephrotoxicity. Kidney Int 69:2194\u20132204","journal-title":"Kidney Int"},{"key":"2958_CR122","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0006-291X(03)01502-X","volume":"308","author":"K Takamoto","year":"2003","unstructured":"Takamoto K, Kawada M, Usui T, Ishizuka M, Ikeda D (2003) Aminoglycoside antibiotics reduce glucose reabsorption in kidney through down-regulation of SGLT1. Biochem Biophys Res Commun 308:866\u2013871","journal-title":"Biochem Biophys Res Commun"},{"key":"2958_CR123","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1021\/tx800061w","volume":"21","author":"EY Xu","year":"2008","unstructured":"Xu EY, Perlina A, Vu H, Troth SP, Brennan RJ, Aslamkhan AG, Xu Q (2008) Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants. Chem Res Toxicol 21:1548\u20131561","journal-title":"Chem Res Toxicol"},{"key":"2958_CR124","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/ndt\/gfh366","volume":"19","author":"S Scholl-Burgi","year":"2004","unstructured":"Scholl-Burgi S, Santer R, Ehrich JH (2004) Long-term outcome of renal glucosuria type 0: the original patient and his natural history. Nephrol Dial Transplant 19:2394\u20132396","journal-title":"Nephrol Dial Transplant"},{"key":"2958_CR125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2215\/CJN.04010609","volume":"5","author":"R Santer","year":"2010","unstructured":"Santer R, Calado J (2010) Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target. Clin J Am Soc Nephrol 5:133\u2013141","journal-title":"Clin J Am Soc Nephrol"},{"key":"2958_CR126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1748-1716.1979.tb06383.x","volume":"106","author":"B Karlmark","year":"1979","unstructured":"Karlmark B, Agerup B, Wistrand PJ (1979) Renal proximal tubular acidification. Role of brush-border and cytoplasmic carbonic anhydrase. Acta Physiol Scand 106:145\u2013150","journal-title":"Acta Physiol Scand"},{"issue":"Suppl 5","key":"2958_CR127","first-page":"S61","volume":"15","author":"GJ Schwartz","year":"2002","unstructured":"Schwartz GJ (2002) Physiology and molecular biology of renal carbonic anhydrase. J Nephrol 15(Suppl 5):S61\u2013S74","journal-title":"J Nephrol"},{"key":"2958_CR128","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/med.20141","volume":"29","author":"JY Winum","year":"2009","unstructured":"Winum JY, Poulsen SA, Supuran CT (2009) Therapeutic applications of glycosidic carbonic anhydrase inhibitors. Med Res Rev 29:419\u2013435","journal-title":"Med Res Rev"},{"key":"2958_CR129","first-page":"F139","volume":"274","author":"S Tsuruoka","year":"1998","unstructured":"Tsuruoka S, Schwartz GJ (1998) HCO3- absorption in rabbit outer medullary collecting duct: role of luminal carbonic anhydrase. Am J Physiol 274:F139\u2013F147","journal-title":"Am J Physiol"},{"key":"2958_CR130","unstructured":"World Health Organization (2012) Global epidemic and health care response. In: Global summary of the HIV\/AIDS epidemic"},{"key":"2958_CR131","unstructured":"World Health Organization (2012) Technical update on treatment optimization: use of tenofovir disoproxil fumarate in HIV-infected children and adolescents aged 2\u201318 years: a public health perspective. WHO HIV\/AIDS Programme"},{"key":"2958_CR132","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/apc.2007.0052","volume":"22","author":"SK Gupta","year":"2008","unstructured":"Gupta SK (2008) Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system. AIDS Patient Care STDS 22:99\u2013103","journal-title":"AIDS Patient Care STDS"},{"key":"2958_CR133","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2011.01.022","volume":"57","author":"AM Hall","year":"2011","unstructured":"Hall AM, Hendry BM, Nitsch D, Connolly JO (2011) Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis 57:773\u2013780","journal-title":"Am J Kidney Dis"},{"key":"2958_CR134","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.106.028233","volume":"71","author":"T Imaoka","year":"2007","unstructured":"Imaoka T, Kusuhara H, Adachi M, Schuetz JD, Takeuchi K, Sugiyama Y (2007) Functional involvement of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol Pharmacol 71:619\u2013627","journal-title":"Mol Pharmacol"},{"key":"2958_CR135","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00467-012-2269-7","volume":"28","author":"AM Hall","year":"2013","unstructured":"Hall AM (2013) Update on tenofovir toxicity in the kidney. Pediatr Nephrol 28:1011\u20131023","journal-title":"Pediatr Nephrol"},{"key":"2958_CR136","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ki.2008.252","volume":"74","author":"AB Liborio","year":"2008","unstructured":"Liborio AB, Andrade L, Pereira LV, Sanches TR, Shimizu MH, Seguro AC (2008) Rosiglitazone reverses tenofovir-induced nephrotoxicity. Kidney Int 74:910\u2013918","journal-title":"Kidney Int"},{"key":"2958_CR137","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pediatrneurol.2009.12.003","volume":"42","author":"A Endo","year":"2010","unstructured":"Endo A, Fujita Y, Fuchigami T, Takahashi S, Mugishima H (2010) Fanconi syndrome caused by valproic acid. Pediatr Neurol 42:287\u2013290","journal-title":"Pediatr Neurol"},{"key":"2958_CR138","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00467-005-1827-7","volume":"20","author":"T Watanabe","year":"2005","unstructured":"Watanabe T, Yoshikawa H, Yamazaki S, Abe Y, Abe T (2005) Secondary renal Fanconi syndrome caused by valproate therapy. Pediatr Nephrol 20:814\u2013817","journal-title":"Pediatr Nephrol"},{"key":"2958_CR139","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ejpn.2002.0585","volume":"6","author":"H Yoshikawa","year":"2002","unstructured":"Yoshikawa H, Watanabe T, Abe T (2002) Fanconi syndrome caused by sodium valproate: report of three severely disabled children. Eur J Paediatr Neurol 6:165\u2013167","journal-title":"Eur J Paediatr Neurol"},{"key":"2958_CR140","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.0013-9580.2004.05504.x","volume":"45","author":"M Knorr","year":"2004","unstructured":"Knorr M, Schaper J, Harjes M, Mayatepek E, Rosenbaum T (2004) Fanconi syndrome caused by antiepileptic therapy with valproic Acid. Epilepsia 45:868\u2013871","journal-title":"Epilepsia"},{"key":"2958_CR141","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/15513819309048273","volume":"13","author":"E Hawkins","year":"1993","unstructured":"Hawkins E, Brewer E (1993) Renal toxicity induced by valproic acid (Depakene). Pediatr Pathol 13:863\u2013868","journal-title":"Pediatr Pathol"},{"key":"2958_CR142","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0022-3476(81)80736-6","volume":"98","author":"GR Lenoir","year":"1981","unstructured":"Lenoir GR, Perignon JL, Gubler MC, Broyer M (1981) Valproic acid: a possible cause of proximal tubular renal syndrome. J Pediatr 98:503\u2013504","journal-title":"J Pediatr"},{"key":"2958_CR143","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000067797","volume":"67","author":"G Alexandridis","year":"2003","unstructured":"Alexandridis G, Liberopoulos E, Elisaf M (2003) Aminoglycoside-induced reversible tubular dysfunction. Pharmacology 67:118\u2013120","journal-title":"Pharmacology"},{"key":"2958_CR144","first-page":"F265","volume":"255","author":"WM Bennett","year":"1988","unstructured":"Bennett WM, Mela-Riker LM, Houghton DC, Gilbert DN, Buss WC (1988) Microsomal protein synthesis inhibition: an early manifestation of gentamicin nephrotoxicity. Am J Physiol 255:F265\u2013F269","journal-title":"Am J Physiol"},{"key":"2958_CR145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0003-9861(80)90103-4","volume":"205","author":"JM Weinberg","year":"1980","unstructured":"Weinberg JM, Harding PG, Humes HD (1980) Mechanisms of gentamicin-induced dysfunction of renal cortical mitochondria. II. Effects on mitochondrial monovalent cation transport. Arch Biochem Biophys 205:232\u2013239","journal-title":"Arch Biochem Biophys"},{"key":"2958_CR146","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.ki.5001654","volume":"70","author":"MC Sassen","year":"2006","unstructured":"Sassen MC, Kim SW, Kwon TH, Knepper MA, Miller RT, Frokiaer J, Nielsen S (2006) Dysregulation of renal sodium transporters in gentamicin-treated rats. Kidney Int 70:1026\u20131037","journal-title":"Kidney Int"},{"key":"2958_CR147","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1345\/aph.1D573","volume":"38","author":"BA Hemstreet","year":"2004","unstructured":"Hemstreet BA (2004) Antimicrobial-associated renal tubular acidosis. Ann Pharmacother 38:1031\u20131038","journal-title":"Ann Pharmacother"},{"key":"2958_CR148","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1254\/jjp.88.69","volume":"88","author":"E Babu","year":"2002","unstructured":"Babu E, Takeda M, Narikawa S, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Sakthisekaran D, Endou H (2002) Human organic anion transporters mediate the transport of tetracycline. Jpn J Pharmacol 88:69\u201376","journal-title":"Jpn J Pharmacol"},{"key":"2958_CR149","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/AAC.47.12.3675-3681.2003","volume":"47","author":"SR Connell","year":"2003","unstructured":"Connell SR, Tracz DM, Nierhaus KH, Taylor DE (2003) Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob Agents Chemother 47:3675\u20133681","journal-title":"Antimicrob Agents Chemother"},{"key":"2958_CR150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0076-6879(06)15012-0","volume":"415","author":"J Wirmer","year":"2006","unstructured":"Wirmer J, Westhof E (2006) Molecular contacts between antibiotics and the 30S ribosomal particle. Methods Enzymol 415:180\u2013202","journal-title":"Methods Enzymol"},{"key":"2958_CR151","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00007611-198706000-00016","volume":"80","author":"LE Anderson","year":"1987","unstructured":"Anderson LE, Henrich WL (1987) Alkalemia-associated morbidity and mortality in medical and surgical patients. South Med J 80:729\u2013733","journal-title":"South Med J"},{"key":"2958_CR152","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archsurg.1972.04180080051009","volume":"105","author":"RF Wilson","year":"1972","unstructured":"Wilson RF, Gibson D, Percinel AK, Ali MA, Baker G, LeBlanc LP, Lucas C (1972) Severe alkalosis in critically ill surgical patients. Arch Surg 105:197\u2013203","journal-title":"Arch Surg"},{"key":"2958_CR153","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/10408369991239286","volume":"36","author":"NR Webster","year":"1999","unstructured":"Webster NR, Kulkarni V (1999) Metabolic alkalosis in the critically ill. Crit Rev Clin Lab Sci 36:497\u2013510","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2958_CR154","first-page":"115","volume":"58","author":"I Leusen","year":"1950","unstructured":"Leusen I (1950) Blood pH, cerebrospinal fluid pH and the respiratory function. Arch Int Physiol 58:115\u2013116","journal-title":"Arch Int Physiol"},{"key":"2958_CR155","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1164\/ajrccm\/141.5_Pt_1.1185","volume":"141","author":"S Brimioulle","year":"1990","unstructured":"Brimioulle S, Kahn RJ (1990) Effects of metabolic alkalosis on pulmonary gas exchange. Am Rev Respir Dis 141:1185\u20131189","journal-title":"Am Rev Respir Dis"},{"key":"2958_CR156","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1172\/JCI106540","volume":"50","author":"AJ Bellingham","year":"1971","unstructured":"Bellingham AJ, Detter JC, Lenfant C (1971) Regulatory mechanisms of hemoglobin oxygen affinity in acidosis and alkalosis. J Clin Invest 50:700\u2013706","journal-title":"J Clin Invest"},{"key":"2958_CR157","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0002-8703(81)80011-7","volume":"102","author":"H Yasue","year":"1981","unstructured":"Yasue H, Omote S, Takizawa A, Nagao M, Nosaka K, Nakajima H (1981) Alkalosis-induced coronary vasoconstriction: effects of calcium, diltiazem, nitroglycerin, and propranolol. Am Heart J 102:206\u2013210","journal-title":"Am Heart J"},{"key":"2958_CR158","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/cs0940287","volume":"94","author":"NR Loon","year":"1998","unstructured":"Loon NR, Wilcox CS (1998) Mild metabolic alkalosis impairs the natriuretic response to bumetanide in normal human subjects. Clin Sci (Lond) 94:287\u2013292","journal-title":"Clin Sci (Lond)"},{"key":"2958_CR159","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1524-6175.2004.03789.x","volume":"6","author":"DA Sica","year":"2004","unstructured":"Sica DA (2004) Diuretic-related side effects: development and treatment. J Clin Hypertens (Greenwich) 6:532\u2013540","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2958_CR160","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-62-5-979","volume":"62","author":"PJ Cannon","year":"1965","unstructured":"Cannon PJ, Heinemann HO, Albert MS, Laragh JH, Winters RW (1965) \"Contraction\" Alkalosis after Diuresis of Edematous Patients with Ethacrynic Acid. Ann Intern Med 62:979\u2013990","journal-title":"Ann Intern Med"},{"key":"2958_CR161","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0002-9343(78)90227-9","volume":"64","author":"WB Schwartz","year":"1978","unstructured":"Schwartz WB, Cohen JJ (1978) The nature of the renal response to chronic disorders of acid\u2013base equilibrium. Am J Med 64:417\u2013428","journal-title":"Am J Med"},{"key":"2958_CR162","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI105807","volume":"47","author":"JJ Cohen","year":"1968","unstructured":"Cohen JJ (1968) Correction of metabolic alkalosis by the kidney after isomertric expansion of extracellular fluid. J Clin Invest 47:1181\u20131192","journal-title":"J Clin Invest"},{"key":"2958_CR163","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1681\/ASN.2011070720","volume":"23","author":"RG Luke","year":"2012","unstructured":"Luke RG, Galla JH (2012) It is chloride depletion alkalosis, not contraction alkalosis. J Am Soc Nephrol 23:204\u2013207","journal-title":"J Am Soc Nephrol"},{"key":"2958_CR164","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1172\/JCI113061","volume":"80","author":"JH Galla","year":"1987","unstructured":"Galla JH, Bonduris DN, Luke RG (1987) Effects of chloride and extracellular fluid volume on bicarbonate reabsorption along the nephron in metabolic alkalosis in the rat. Reassessment of the classical hypothesis of the pathogenesis of metabolic alkalosis. J Clin Invest 80:41\u201350","journal-title":"J Clin Invest"},{"key":"2958_CR165","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/bmj.4.5630.550","volume":"4","author":"FP Brunner","year":"1968","unstructured":"Brunner FP, Frick PG (1968) Hypokalaemia, metabolic alkalosis, and hypernatraemia due to \"massive\" sodium penicillin therapy. Br Med J 4:550\u2013552","journal-title":"Br Med J"},{"key":"2958_CR166","first-page":"183","volume":"86","author":"HI Lipner","year":"1975","unstructured":"Lipner HI, Ruzany F, Dasgupta M, Lief PD, Bank N (1975) The behavior of carbenicillin as a nonreabsorbable anion. J Lab Clin Med 86:183\u2013194","journal-title":"J Lab Clin Med"},{"key":"2958_CR167","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jac\/dkn117","volume":"61","author":"EJ Hoorn","year":"2008","unstructured":"Hoorn EJ, Zietse R (2008) Severe hypokalaemia caused by flucloxacillin. J Antimicrob Chemother 61:1396\u20131398","journal-title":"J Antimicrob Chemother"},{"key":"2958_CR168","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/01.ASN.0000015623.73739.B8","volume":"13","author":"DT Ward","year":"2002","unstructured":"Ward DT, McLarnon SJ, Riccardi D (2002) Aminoglycosides increase intracellular calcium levels and ERK activity in proximal tubular OK cells expressing the extracellular calcium-sensing receptor. J Am Soc Nephrol 13:1481\u20131489","journal-title":"J Am Soc Nephrol"},{"key":"2958_CR169","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1681\/ASN.2004080631","volume":"16","author":"DT Ward","year":"2005","unstructured":"Ward DT, Maldonado-Perez D, Hollins L, Riccardi D (2005) Aminoglycosides induce acute cell signaling and chronic cell death in renal cells that express the calcium-sensing receptor. J Am Soc Nephrol 16:1236\u20131244","journal-title":"J Am Soc Nephrol"},{"key":"2958_CR170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-291X(02)02133-2","volume":"297","author":"S McLarnon","year":"2002","unstructured":"McLarnon S, Holden D, Ward D, Jones M, Elliott A, Riccardi D (2002) Aminoglycoside antibiotics induce pH-sensitive activation of the calcium-sensing receptor. Biochem Biophys Res Commun 297:71\u201377","journal-title":"Biochem Biophys Res Commun"},{"key":"2958_CR171","first-page":"F611","volume":"274","author":"D Riccardi","year":"1998","unstructured":"Riccardi D, Hall AE, Chattopadhyay N, Xu JZ, Brown EM, Hebert SC (1998) Localization of the extracellular Ca2+\/polyvalent cation-sensing protein in rat kidney. Am J Physiol 274:F611\u2013F622","journal-title":"Am J Physiol"},{"key":"2958_CR172","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0272-6386(12)81064-X","volume":"24","author":"CJ Shiah","year":"1994","unstructured":"Shiah CJ, Tsai DM, Liao ST, Siauw CP, Lee LS (1994) Acute muscular paralysis in an adult with subclinical Bartter's syndrome associated with gentamicin administration. Am J Kidney Dis 24:932\u2013935","journal-title":"Am J Kidney Dis"},{"key":"2958_CR173","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJM197602122940703","volume":"294","author":"P Szylman","year":"1976","unstructured":"Szylman P, Better OS, Chaimowitz C, Rosler A (1976) Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism. N Engl J Med 294:361\u2013365","journal-title":"N Engl J Med"},{"key":"2958_CR174","first-page":"576","volume":"49","author":"CK Finton","year":"1983","unstructured":"Finton CK, Bjorkland S, Zaloga GP, Uddin DE, Chernow B (1983) Gentamicin-induced hypomagnesemia. Am Surg 49:576\u2013578","journal-title":"Am Surg"},{"key":"2958_CR175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1067\/mcp.2000.103864","volume":"67","author":"C Elliott","year":"2000","unstructured":"Elliott C, Newman N, Madan A (2000) Gentamicin effects on urinary electrolyte excretion in healthy subjects. Clin Pharmacol Ther 67:16\u201321","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"2958_CR176","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000139853","volume":"47","author":"SA Muller-Lissner","year":"1993","unstructured":"Muller-Lissner SA (1993) Adverse effects of laxatives: fact and fiction. Pharmacology 47(Suppl 1):138\u2013145","journal-title":"Pharmacology"},{"key":"2958_CR177","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.emc.2007.02.011","volume":"25","author":"DL Eldridge","year":"2007","unstructured":"Eldridge DL, Van Eyk J, Kornegay C (2007) Pediatric toxicology. Emerg Med Clin North Am 25:283\u2013308, abstract vii-viii","journal-title":"Emerg Med Clin North Am"},{"key":"2958_CR178","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00000441-200605000-00001","volume":"331","author":"DP Beall","year":"2006","unstructured":"Beall DP, Henslee HB, Webb HR, Scofield RH (2006) Milk-alkali syndrome: a historical review and description of the modern version of the syndrome. Am J Med Sci 331:233\u2013242","journal-title":"Am J Med Sci"},{"key":"2958_CR179","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1681\/ASN.2010030255","volume":"21","author":"AM Patel","year":"2010","unstructured":"Patel AM, Goldfarb S (2010) Got calcium? Welcome to the calcium-alkali syndrome. J Am Soc Nephrol 21:1440\u20131443","journal-title":"J Am Soc Nephrol"},{"key":"2958_CR180","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1542\/peds.2008-1862","volume":"122","author":"CL Wagner","year":"2008","unstructured":"Wagner CL, Greer FR (2008) Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 122:1142\u20131152","journal-title":"Pediatrics"},{"key":"2958_CR181","doi-asserted-by":"crossref","first-page":"e1060","DOI":"10.1542\/peds.2011-1663","volume":"129","author":"MB Vanstone","year":"2012","unstructured":"Vanstone MB, Oberfield SE, Shader L, Ardeshirpour L, Carpenter TO (2012) Hypercalcemia in children receiving pharmacologic doses of vitamin D. Pediatrics 129:e1060\u2013e1063","journal-title":"Pediatrics"},{"key":"2958_CR182","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4065\/84.3.261","volume":"84","author":"BI Medarov","year":"2009","unstructured":"Medarov BI (2009) Milk-alkali syndrome. Mayo Clin Proc 84:261\u2013267","journal-title":"Mayo Clin Proc"},{"key":"2958_CR183","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2215\/CJN.01451005","volume":"1","author":"AJ Felsenfeld","year":"2006","unstructured":"Felsenfeld AJ, Levine BS (2006) Milk alkali syndrome and the dynamics of calcium homeostasis. Clin J Am Soc Nephrol 1:641\u2013654","journal-title":"Clin J Am Soc Nephrol"},{"key":"2958_CR184","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/01.CCM.0000134831.40466.39","volume":"32","author":"AC Arroliga","year":"2004","unstructured":"Arroliga AC, Shehab N, McCarthy K, Gonzales JP (2004) Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit Care Med 32:1709\u20131714","journal-title":"Crit Care Med"},{"key":"2958_CR185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneph.2009.17","volume":"5","author":"R Zietse","year":"2009","unstructured":"Zietse R, Zoutendijk R, Hoorn EJ (2009) Fluid, electrolyte and acid\u2013base disorders associated with antibiotic therapy. Nat Rev Nephrol 5:193\u2013202","journal-title":"Nat Rev Nephrol"},{"key":"2958_CR186","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ki.1995.266","volume":"48","author":"JH Galla","year":"1995","unstructured":"Galla JH, Rome L, Luke RG (1995) Bicarbonate transport in collecting duct segments during chloride-depletion alkalosis. Kidney Int 48:52\u201355","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2958-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-014-2958-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2958-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T05:25:07Z","timestamp":1650518707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-014-2958-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,5]]},"references-count":186,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["2958"],"URL":"https:\/\/doi.org\/10.1007\/s00467-014-2958-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,5]]}}}